3

MAIN DOCUMENT DESCRIPTION

Company: Protalix BioTherapeutics, Inc.
Filed: September 7, 2010
Period of Report: August 29, 2010
Accession Number: 0001209191-10-045332

View Document ↗ View on SEC.gov ↗